var title_f36_39_37488="Ventricular septal defect MRI";
var content_f36_39_37488=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77523&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ventricular septal defect by echocardiography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Complete atrioventricular canal defect. The arrow depicts the ventricular septal defect.",
"    <br/>",
"    (B) Mid muscular ventricular septal defect (arrow).",
"    <div class=\"footnotes\">",
"     RV: right ventricle; LV: left ventricle.",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37488=[""].join("\n");
var outline_f36_39_37488=null;
var title_f36_39_37489="Patient information: Bedwetting in children (The Basics)";
var content_f36_39_37489=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?7/9/7315\">",
"         Patient information: Bedwetting in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?42/45/43730\">",
"         Patient information: Toilet training (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Bedwetting in children (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/bedwetting-in-children-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H46413168\">",
"      <span class=\"h1\">",
"       Is it normal for my child to wet the bed at night?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, it can be normal. Wetting the bed at night is common in young children. By age 4, most children can control their bladder when they are awake. But it can take longer for children to have control over their bladder when they are sleeping. Some children do not stop wetting the bed at night until they are 5 to 7 years old. Bedwetting is more common in boys than in girls, and can run in families.",
"     </p>",
"     <p>",
"      Most children will stop bedwetting on their own and do not need any treatment. But if you are worried or have questions about your child&rsquo;s bedwetting, talk with your child&rsquo;s doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46413175\">",
"      <span class=\"h1\">",
"       Why do children wet the bed?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bedwetting is most likely to happen when:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A child&rsquo;s bladder muscles develop more slowly than usual",
"       </li>",
"       <li>",
"        A child&rsquo;s bladder holds a smaller than normal amount of urine",
"       </li>",
"       <li>",
"        A child&rsquo;s body makes a lot of urine",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Most of the time, bedwetting is not caused by a medical or emotional problem. In some cases, though, it is. Your doctor should be able to tell if your child&rsquo;s bedwetting is caused by a medical problem.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46413182\">",
"      <span class=\"h1\">",
"       What can I do to try to stop my child&rsquo;s bedwetting?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can try different things at home to stop your child&rsquo;s bedwetting.",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Have your child urinate before going to bed. Remind him or her to wake up and use the toilet when needed.",
"       </li>",
"       <li>",
"        Put night lights in the hall and bathroom so your child can find the toilet easily.",
"       </li>",
"       <li>",
"        Stop using diapers or training pants at home, especially if your child is older than 8. Your child can still wear those items for overnight visits with family and friends.",
"       </li>",
"       <li>",
"        Have your child help with clean up in the morning. For example, he or she can take the wet sheet off the bed or help with laundry.",
"       </li>",
"       <li>",
"        Keep a chart of your child&rsquo;s progress and give rewards when your child stays dry. You and your child should agree on the rewards ahead of time.",
"       </li>",
"       <li>",
"        Spread out your child&rsquo;s drinks over the whole day. Do not have your child drink a lot right before bedtime.",
"       </li>",
"       <li>",
"        Help your child teach his or her bladder to hold more urine. Have your child hold his or her urine for longer periods of time before urinating.",
"       </li>",
"       <li>",
"        Use a night-time bedwetting alarm. Alarms work best in children ages 7 and older. Talk with your doctor about which type of alarm is best for your child and how to use it.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      For any of these plans to work, both you and your child must want the bedwetting to stop. Stopping bedwetting can be very hard to do and can take a long time.",
"     </p>",
"     <p>",
"      Remember that children cannot help their bedwetting. You should never get mad at, punish, or tease your child for wetting the bed.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46413189\">",
"      <span class=\"h1\">",
"       Are there tips for how to keep my child&rsquo;s bed clean and dry?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Use a waterproof sheet to protect the mattress and avoid urine odor. When your child wets the bed at night, have him or her use the toilet before putting on dry pajamas. Then, put a dry towel on the wet part of the bed. You can also make the bed in layers, alternating sheets with waterproof pads. Then, when your child wets the bed, you can just take the wet sheet off without needing to re-make the bed.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46413196\">",
"      <span class=\"h1\">",
"       When should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You should see your doctor or nurse if your child:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feels the need to urinate more than usual",
"       </li>",
"       <li>",
"        Is more thirsty than usual",
"       </li>",
"       <li>",
"        Has a burning feeling when he or she urinates",
"       </li>",
"       <li>",
"        Has swelling of the feet or ankles",
"       </li>",
"       <li>",
"        Starts wetting the bed again after being dry for weeks or months",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These symptoms can be a sign of a medical problem. Your child&rsquo;s doctor will want to check him or her. The doctor will do an exam and might order tests, including a urine test.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46413203\">",
"      <span class=\"h1\">",
"       Are there medicines that can reduce bedwetting?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. There are medicines doctors can prescribe to reduce bedwetting. But medicines are usually given to children older than 7 who have already tried many other ways to stop bedwetting.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46413210\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/9/7315?source=see_link\">",
"       Patient information: Bedwetting in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?42/45/43730?source=see_link\">",
"       Patient information: Toilet training (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?36/39/37489?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15347 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-3918385851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37489=[""].join("\n");
var outline_f36_39_37489=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46413168\">",
"      Is it normal for my child to wet the bed at night?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46413175\">",
"      Why do children wet the bed?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46413182\">",
"      What can I do to try to stop my child&rsquo;s bedwetting?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46413189\">",
"      Are there tips for how to keep my child&rsquo;s bed clean and dry?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46413196\">",
"      When should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46413203\">",
"      Are there medicines that can reduce bedwetting?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46413210\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/9/7315?source=related_link\">",
"      Patient information: Bedwetting in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?42/45/43730?source=related_link\">",
"      Patient information: Toilet training (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_39_37490="Upper endoscopy PI";
var content_f36_39_37490=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F75392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F75392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Upper endoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 673px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    During an upper endoscopy, you lie down and the doctor puts a thin tube with a camera and light on the end (called an endoscope) into your mouth and down into your esophagus, stomach, and duodenum (the first part of your small intestine). The camera sends video pictures from inside your body to a television screen. That way, your doctor can see the inside of your esophagus, stomach, and duodenum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37490=[""].join("\n");
var outline_f36_39_37490=null;
var title_f36_39_37491="Percutaneous transhepatic cholangiography";
var content_f36_39_37491=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Percutaneous transhepatic cholangiography",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37491/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37491/contributors\">",
"     Jonathan B Kruskal, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37491/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37491/contributors\">",
"     Sanjiv Chopra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37491/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37491/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/39/37491/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous transhepatic cholangiography (PTC) involves transhepatic insertion of a needle into a bile duct, followed by injection of contrast material to opacify the bile ducts. PTC is usually performed for evaluation of patients who are found to have biliary duct dilation on ultrasonography or other imaging tests and who are not candidates for endoscopic retrograde cholangiopancreatography (ERCP). Included in this group are patients who have surgically altered anatomy preventing endoscopic access to the biliary tree and those in whom ERCP was unsuccessful. PTC has close to 100 percent sensitivity and specificity for identifying the cause and site of biliary tract obstruction, being more accurate in this regard than ultrasonography or CT scan.",
"   </p>",
"   <p>",
"    PTC also permits a number of therapeutic interventions, including drainage of infected bile in the setting of cholangitis, extraction of biliary tract stones, dilation of benign biliary strictures, or placement of a stent across a malignant stricture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the basic aspects of the technique of PTC and the complications that may be seen. The clinical utility of PTC in different disease states is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/50/42790?source=see_link\">",
"     \"Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;PTC is usually performed in patients with dilated bile ducts, which are easily recognized on transabdominal ultrasound or with all cross-sectional imaging modalities, including magnetic resonance cholangiopancreatography. These imaging studies are useful for planning the site of needle insertion during PTC, especially if ductal dilation involves only one or a few liver segments. PTC may be technically limited and associated with a higher incidence of complications in the absence of dilatation of the intrahepatic ducts, although it has been performed successfully in some settings, such as in patients with postoperative biliary leaks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the percutaneous catheter traverses skin, intercostal muscles, and the liver capsule, the procedure can be painful and should be performed using local anesthesia and conscious sedation. Sedation is particularly important if additional procedures such as biopsy or stent insertion are planned. Some institutions prefer to use an intercostal nerve block, which may not reduce pain arising from puncture of the liver capsule or from intrahepatic manipulations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=see_link\">",
"     \"Procedural sedation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous antibiotic prophylaxis should be given prior to PTC in patients with obstructive jaundice. It is important to select antibiotics that include coverage of Enterococcus sp and gram-negative bacillus, both of which are found in infected bile ducts. In addition to antibiotic prophylaxis, the bile ducts should be decompressed prior to contrast injection, because injection into a dilated system can result in biliary sepsis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=see_link\">",
"     \"Acute cholangitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Access sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous access to the biliary tree is usually via the left or right hepatic ducts, but can also be achieved through puncture of the gallbladder. The left hepatic duct is preferred because the subcostal route used to access the left hepatic duct is less painful than the intercostal route used to approach the right hepatic duct, and because accessing the left duct is less likely to transgress the pleural space [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cannulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Using ultrasound or fluoroscopic guidance, a peripheral bile duct is punctured with a 21-gauge needle, and position confirmed with injection of a small volume of contrast material. A guidewire is then inserted through the needle into a central bile duct, and a plastic drainage cannula is passed over the guidewire. Insertion of the cannula may require the use of sheaths and dilators to distend the tract.",
"   </p>",
"   <p>",
"    A catheter can then be inserted through the cannula and can be advanced across an obstruction into the duodenum, thereby draining bile internally and externally. Adequate drainage is usually confirmed by a steady decline in serum bilirubin concentrations. Drainage from an infected system is slower than from a noninfected tract due to the greater viscosity of infected bile. The external limb of the catheter can be closed to enhance internal drainage and preserve the enterohepatic bile salt circulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Access to the biliary tree permits a number of diagnostic and therapeutic interventions. As an example, sclerosing cholangitis and cholangiocarcinoma are two diseases in which the intrahepatic bile ducts may not easily be opacified via ERCP. In this setting, PTC is useful for documenting the extent of disease, obtaining tissue for histological diagnosis, dilating a stricture, or inserting a stent to relieve obstruction (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82582 \" href=\"mobipreview.htm?38/58/39842\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53993 \" href=\"mobipreview.htm?39/57/40849\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62207 \" href=\"mobipreview.htm?26/54/27491\">",
"     image 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22521?source=see_link\">",
"     \"Clinical manifestations and diagnosis of primary sclerosing cholangitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/43/40633?source=see_link\">",
"     \"Clinical manifestations and diagnosis of cholangiocarcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stones, sludge, or blood clots can also be removed during PTC and access to the biliary tree accomplished during PTC can facilitate subsequent interventions via ERCP by placement of a guidewire. Biopsies and brushings can be obtained when malignancy is suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=see_link\">",
"     \"Endoscopic methods for the diagnosis of pancreatobiliary neoplasms\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, bacteremia is a potential complication of PTC that warrants antibiotic prophylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/7\">",
"     7",
"    </a>",
"    ]. However, the risk of cholangitis and sepsis is low. In one study of 154 patients, the rate of cholangitis following cholangiography with subsequent biliary drain exchange was 2 percent, and the rate of sepsis was 0.4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another complication is hemobilia resulting from communication of the tract with a major vascular structure. In one series of 333 procedures, severe hemobilia occurred in 4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/9\">",
"     9",
"    </a>",
"    ]. Hepatic arteriography was used to identify the source of bleeding, which included hepatic artery pseudoaneurysms in nine patients, hepatic artery-bile duct fistulae in four, and a hepatic artery-portal vein fistula in one patient. Transcatheter embolization effectively stopped the bleeding in all cases. Embolization agents used included Hilal embolization microcoils, occluding spring emboli, cyanoacrylate, detachable balloons, and gelatin sponge pledgets. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24616?source=see_link\">",
"     \"Angiographic control of nonvariceal gastrointestinal bleeding in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a second series with 3110 patients who underwent 3780 percutaneous transhepatic biliary drainage procedures, hepatic arterial injury occurred after 72 procedures (2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37491/abstract/10\">",
"     10",
"    </a>",
"    ]. Left-sided puncture was the only independent risk factor for hepatic arterial injury (odds ratio 2.0). All patients were treated with transcatheter embolization, with technical and clinical success rates of 100 and 96 percent, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Percutaneous transhepatic cholangiography (PTC) involves transhepatic insertion of a needle into a bile duct, followed by injection of contrast material to opacify the bile ducts. It is usually performed for evaluation of patients who are found to have biliary duct dilation on ultrasonography or other imaging tests and who are not candidates for endoscopic retrograde cholangiopancreatography. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The technique for PTC and the role of antibiotic prophylaxis are described above. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Access to the biliary tree permits a number of diagnostic and therapeutic interventions including dilation, brushings, and biopsies of biliary strictures, removal of intrahepatic stones, and placement of a stent or a guidewire to facilitate subsequent ERCP. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Interventions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/1\">",
"      Kavanagh PV, vanSonnenberg E, Wittich GR, et al. Interventional radiology of the biliary tract. Endoscopy 1997; 29:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/2\">",
"      Teplick SK, Flick P, Brandon JC. Transhepatic cholangiography in patients with suspected biliary disease and nondilated intrahepatic bile ducts. Gastrointest Radiol 1991; 16:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/3\">",
"      Cozzi G, Severini A, Civelli E, et al. Percutaneous transhepatic biliary drainage in the management of postsurgical biliary leaks in patients with nondilated intrahepatic bile ducts. Cardiovasc Intervent Radiol 2006; 29:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/4\">",
"      K&uuml;hn JP, Busemann A, Lerch MM, et al. Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts compared with patients with dilated intrahepatic bile ducts. AJR Am J Roentgenol 2010; 195:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/5\">",
"      Wu SM, Marchant LK, Haskal ZJ. Percutaneous interventions in the biliary tree. Semin Roentgenol 1997; 32:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/6\">",
"      Hayashi N, Sakai T, Kitagawa M, et al. US-guided left-sided biliary drainage: nine-year experience. Radiology 1997; 204:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/7\">",
"      Ozden I, Tekant Y, Bilge O, et al. Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg 2005; 189:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/8\">",
"      Ginat D, Saad WE, Davies MG, et al. Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients. AJR Am J Roentgenol 2011; 196:W73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/9\">",
"      Savader SJ, Trerotola SO, Merine DS, et al. Hemobilia after percutaneous transhepatic biliary drainage: treatment with transcatheter embolotherapy. J Vasc Interv Radiol 1992; 3:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37491/abstract/10\">",
"      Choi SH, Gwon DI, Ko GY, et al. Hepatic arterial injuries in 3110 patients following percutaneous transhepatic biliary drainage. Radiology 2011; 261:969.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 671 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-CC23815824-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37491=[""].join("\n");
var outline_f36_39_37491=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Access sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cannulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/671\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/671|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?38/58/39842\" title=\"diagnostic image 1\">",
"      PTC cholangiocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?26/54/27491\" title=\"diagnostic image 2\">",
"      PTC Klatskin tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?39/57/40849\" title=\"picture 1\">",
"      Choledochoduodenal strictur",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=related_link\">",
"      Acute cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24616?source=related_link\">",
"      Angiographic control of nonvariceal gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/43/40633?source=related_link\">",
"      Clinical manifestations and diagnosis of cholangiocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/63/22521?source=related_link\">",
"      Clinical manifestations and diagnosis of primary sclerosing cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/50/42790?source=related_link\">",
"      Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19816?source=related_link\">",
"      Endoscopic methods for the diagnosis of pancreatobiliary neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=related_link\">",
"      Procedural sedation in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_39_37492="Skin changes of chronic venous insufficiency";
var content_f36_39_37492=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56758%7EPC%2F71020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56758%7EPC%2F71020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Skin changes of chronic venous insufficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 262px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Longstanding edema in this patient with chronic venous insufficiency led to moderately advanced pigment changes on the medial and lateral ankles, which extend onto the dorsum of the foot. The left medial ankle displays a healed venous ulcer below the malleolus; the right lateral ankle has a small, active, venous ulcer (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrick C Alguire, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Venous stasis ulcer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 214px; height: 271px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large venous ulcer on the medial ankle in a patient with chronic venous stasis. The ulcer is shallow and red-based with irregular borders.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrick C Alguire, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37492=[""].join("\n");
var outline_f36_39_37492=null;
var title_f36_39_37493="Hodgkins disease - low power";
var content_f36_39_37493=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hodgkin's disease involving the liver in a 58-year-old man (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Portal triads are greatly expanded by an array of atypical mononuclear inflammatory cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37493=[""].join("\n");
var outline_f36_39_37493=null;
var title_f36_39_37494="Ethinyl estradiol and etonogestrel: Patient drug information";
var content_f36_39_37494=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ethinyl estradiol and etonogestrel: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/27/25017?source=see_link\">",
"     see \"Ethinyl estradiol and etonogestrel: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F169212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      NuvaRing&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F855130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      NuvaRing&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700860",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not smoke while using this contraceptive ring. Cigarette smoking raises the chance of very bad heart and blood-related side effects. This chance is higher with age (older than 35 years of age) and with heavy smoking (15 or more cigarettes per day). This contraceptive ring does not stop the spread of diseases caused by having sex.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691546",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop pregnancy.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ethinyl estradiol, etonogestrel, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Blood clots, breast cancer, diseased arteries in the brain, disease of a heart valve with problems, endometrial cancer, heart disease, high blood pressure, liver disease, liver tumor, very bad headache, tumor where estrogen makes it grow, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have surgery and need bed rest.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: High blood sugar (diabetes) or poor blood flow.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701021",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a heavy smoker (more than 15 cigarettes per day) and older than 35 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have not started your period.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you turned yellow during pregnancy or with estrogen-based or hormone contraceptive use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696917",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use a diaphragm while using this ring.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698524",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), you will need to watch your blood sugar closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are going to have surgery and will not be able to move around for awhile, stop this drug. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do monthly breast self-exams and have a gynecologic exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort, dong quai, black cohosh, saw palmetto, red clover, or ginseng with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698514",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the ring is out for more than 1 week, take a pregnancy test before starting the next dosing cycle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaginal irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Period (menstrual) changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in how contact lenses feel in the eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use as you have been told by your doctor or read the package insert.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put into the vagina and leave in place for 3 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695579",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out ring at the start of the 4th week.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put in a new ring 7 days later.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695227",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put it in at the same time of day that the one before was taken out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696135",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To use, wash your hands and take ring from the pouch. Keep the pouch to throw away the ring later.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Press sides of ring at the same time between thumb and index finger and put folded ring into the vagina.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695506",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Perfect placement is not needed for the ring to work. The ring will not hurt.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To take off, hook your index finger around the rim or hold rim between index finger and middle finger and pull out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694778",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not throw the vaginal ring in the toilet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698535",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you miss 2 periods in a row, take a pregnancy test before starting a new dosing cycle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696506",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the ring is taken out at any time during the 3 weeks of use, rinse it off with lukewarm water and put it back in as soon as you can.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696508",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the ring is taken out for more than 3 hours, you must use a helpful kind of birth control (not a diaphragm) for 7 days after putting the ring back in.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696507",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the ring is taken out for more than 1 week, you must use a helpful kind of birth control (not a diaphragm) for 7 days after putting the ring back in.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696550",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Missed dosing facts may be found in the package insert or call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699576",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store unused rings at room temperature. Throw away any unused rings after 4 months.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12447 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-528937E1C1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37494=[""].join("\n");
var outline_f36_39_37494=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169212\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F855130\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027248\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027250\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027249\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027254\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027255\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027257\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027252\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027253\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027258\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027259\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/27/25017?source=related_link\">",
"      Ethinyl estradiol and etonogestrel: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_39_37495="Treatment of HIV-infected adults who have trouble swallowing pills: Liquid, chewable, and crushable formulations";
var content_f36_39_37495=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of HIV-infected adults who have trouble swallowing pills: Liquid, chewable, and crushable formulations",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37495/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37495/contributors\">",
"     Amy L Graziani, PharmD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37495/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37495/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37495/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37495/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/39/37495/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiretroviral therapy (ART) is recommended in all HIV-infected patients, regardless of CD4 cell count [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/1\">",
"     1",
"    </a>",
"    ]. However, some patients may have trouble taking combination regimens if they have difficulty swallowing due to other comorbidities, such as candidal esophagitis, or more permanent disabilities, such as stroke.",
"   </p>",
"   <p>",
"    Fortunately, many antiretroviral medications are available as liquid preparations. In addition, for some medications there are methods for dissolving or crushing tablets, which are effective without losing drug potency.",
"   </p>",
"   <p>",
"    Medication dosing options for the patient who has difficulty swallowing is reviewed below. Information about the general approach to selecting combination ART is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to understand that the milligram dosing of a liquid preparation may differ from the milligram dose of a tablet formulation, so a direct conversion shouldn&rsquo;t be expected. A summary of the available liquid formulations is found in the accompanying table (",
"    <a class=\"graphic graphic_table graphicRef71499 \" href=\"mobipreview.htm?25/19/25916\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The manufacturer does not usually provide a measuring device in the packaging for most of these liquid products. In addition, pharmacists generally do not provide instruction or measuring devices unless specifically asked and they may not have time to properly instruct patients on how to use them. Therefore, patients often use whatever they consider to be a teaspoon, tablespoon, or ounce, all of which are significantly inaccurate. The volume of liquid delivered via various household teaspoons can range from 2 mL to 9 mL.",
"   </p>",
"   <p>",
"    Thus, it is important that the clinician instruct the patient to use a calibrated measuring device such as a plastic medication cup, medication spoon, or an oral syringe. We keep a sham liquid medication bottle filled with water and plastic medication cups, medication spoons, and oral syringes on hand in the office since these tools are helpful for patient demonstration and to verify that the patient or caregiver is able to measure accurately. Patients are first instructed on proper measurement techniques and then are asked to demonstrate accurate measuring of the sham medication.",
"   </p>",
"   <p>",
"    Coformulated tablets are available for many antiretroviral medications, which will decrease pill burden, if the number of pills is troubling. Alternatively, if pill size is an issue, a smaller strength tablet may be helpful since it is physically smaller in size, although patients will have to ingest a greater number of pills per dose.",
"   </p>",
"   <p>",
"    When liquid formulations are desired, attention should be paid to palatability, as described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     AVAILABILITY OF ALTERNATIVE FORMULATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most pharmacies do not routinely stock liquid formulations of antiretroviral medicines. However, the required formulation can generally be obtained from the wholesaler within one to two business days. Insurance companies may require \"prior authorization\" forms or may deny full coverage because some of the liquids are more expensive than the solid formulations.",
"   </p>",
"   <p>",
"    Some of these products are quite expensive and are packaged in sizes conducive to pediatric, not adult, dosing. Therefore, some bottles may last only a few days. Additionally, some medications require reconstitution by the pharmacist and may have limited stability once reconstituted, as detailed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4522885\">",
"    <span class=\"h1\">",
"     NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;First-line agents for the treatment of HIV in the class nucleoside reverse transcriptase inhibitors (NRTIs) include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/63/31734?source=see_link\">",
"     abacavir",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/7/38007?source=see_link\">",
"     lamivudine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/2\">",
"     2",
"    </a>",
"    ]. Abacavir is also considered a preferred agent if genetic testing for HLA-B*5701 is negative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=see_link&amp;anchor=H29#H29\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\", section on 'Nucleoside analogs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21049?source=see_link\">",
"     \"Abacavir hypersensitivity reaction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4522951\">",
"    <span class=\"h2\">",
"     Tenofovir (Viread)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2012, an oral powder formulation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    became available in 60 g bottles which should last approximately eight days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/4\">",
"     4",
"    </a>",
"    ]. Patients with normal renal function who weigh &gt;35 kg should receive 7.5 &ldquo;scoops&rdquo; of tenofovir powder, which is equivalent to the standard 300 mg dose in the tablet formulation.",
"   </p>",
"   <p>",
"    The white granules should be mixed in one cup of soft food (eg, yogurt, pudding, apple sauce) and ingested immediately; patients should be instructed not to chew the granules, which are bitter in taste.",
"   </p>",
"   <p>",
"    The 300 mg tablet of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    is a triangular-shaped, water soluble, non-enteric coated pill. When crushed, it will dissolve in 100 mL of water. However, there are no data on the stability or pharmacokinetics of the drug with this approach and the powder within the tablet has a bitter taste.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     Tenofovir",
"    </a>",
"    is also available in 150, 200, and 250 mg strengths, which are somewhat smaller than the 300 mg tablet, and may alleviate some of the difficulties with swallowing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523069\">",
"    <span class=\"h2\">",
"     Emtricitabine (Emtriva)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     Emtricitabine",
"    </a>",
"    is available as a clear, orange liquid, which comes with a calibrated dosing cup. Pharmacists should store emtricitabine in the refrigerator, but patients can store it at room temperature (77&ordm;F) if they use it within three months. The small 170 mL bottles will last approximately seven days.",
"   </p>",
"   <p>",
"    The liquid adult dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    is",
"    <strong>",
"     NOT",
"    </strong>",
"    equivalent to the capsule dose. As an example, a patient with normal renal function would take 200 mg daily of the capsule formulation, while the oral solution dose would be 240 mg (24 mL) once daily.",
"   </p>",
"   <p>",
"    The powder within the capsule is water soluble and is non-enteric coated or sustained release and, therefore, the capsule could theoretically be opened and dissolved in water. However, there are no data on the stability, pharmacokinetics, and tolerability of the drug following opening of the capsule and dissolution in water.",
"   </p>",
"   <p>",
"    In patients taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    , pill burden may be reduced by using the coformulated combination tablet of emtricitabine 200 mg plus tenofovir 300 mg (eg, Truvada, 1 tablet daily).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853541\">",
"    <span class=\"h2\">",
"     Truvada (tenofovir-emtricitabine)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly used form of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    is within the coformulated tablet (Truvada), which also includes",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    . This is not available in a liquid form, but the individual components can be prescribed separately. There is no liquid formulation for Truvada; however, its individual components can be given in liquid form, as noted above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Abacavir (Ziagen)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/63/31734?source=see_link\">",
"     Abacavir",
"    </a>",
"    is available as a 20",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    solution in 240 mL bottles, which can be stored at room temperature. The solution is yellow in color and strawberry-banana flavored. The usual dose for an adult is 15 mL (300 mg) orally twice daily or 30 mL (600 mg) once daily. A 240 mL bottle should last eight days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523179\">",
"    <span class=\"h2\">",
"     Lamivudine (Epivir, 3TC)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/7/38007?source=see_link\">",
"     Lamivudine",
"    </a>",
"    is available as an oral solution containing 10",
"    <span class=\"nowrap\">",
"     mg/1",
"    </span>",
"    mL in 240 mL bottles. The liquid is clear pale yellow or colorless. The preparation has a strawberry-banana flavor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853848\">",
"    <span class=\"h2\">",
"     Zidovudine (Retrovir, ZDV, AZT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the small 100 mg capsule and medium-sized round 300 mg tablet,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    is available as a syrup containing 50",
"    <span class=\"nowrap\">",
"     mg/5",
"    </span>",
"    mL in 240 mL bottles. The liquid is colorless to pale yellow in appearance and has a strawberry flavor.",
"   </p>",
"   <p>",
"    There is also a parenteral intravenous formulation available (10",
"    <span class=\"nowrap\">",
"     mg/mL)",
"    </span>",
"    that is used during labor and delivery for the HIV-infected pregnant female.",
"   </p>",
"   <p>",
"    For patients who prefer a smaller size capsule to the medium-sized round 300 mg tablet, there are smaller 100 mg capsules, which may be easier to swallow, although it will increase pill burden.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4522930\">",
"    <span class=\"h2\">",
"     Combivir (zidovudine-lamivudine)",
"    </span>",
"    &nbsp;&mdash;&nbsp;No liquid formulation is available for this combination product. However, there are liquid formulations available for the individual components of the product; see",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/7/38007?source=see_link\">",
"     lamivudine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4522980\">",
"    <span class=\"h1\">",
"     NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first-line drug choice within the non-nucleoside reverse transcriptase inhibitor (NNRTI) class is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    , which is usually given in combination with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    as Atripla [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/2\">",
"     2",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15798?source=see_link\">",
"     Rilpivirine",
"    </a>",
"    is an alternate agent for treatment-na&iuml;ve patients who do not have high baseline HIV RNA (ie, &gt;100,000",
"    <span class=\"nowrap\">",
"     copies/mL).",
"    </span>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13320?source=see_link\">",
"     Etravirine",
"    </a>",
"    is potent against wild-type and some drug-resistant strains of HIV. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/26/34218?source=see_link&amp;anchor=H29#H29\">",
"     \"Primer on interpretation of HIV drug resistance testing\", section on 'Non-nucleoside reverse transcriptase inhibitors (NNRTIs)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/14/34024?source=see_link\">",
"     \"Treatment of drug-resistant genital herpes simplex virus infection in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27994?source=see_link&amp;anchor=H7365374#H7365374\">",
"     \"Selection of antiretroviral therapy for the treatment-experienced patient with drug-resistant HIV infection\", section on 'Resistance to nonnucleoside reverse transcriptase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523010\">",
"    <span class=\"h2\">",
"     Efavirenz (Sustiva)",
"    </span>",
"    &nbsp;&mdash;&nbsp;No liquid formulation for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    is available in the United States, although one is under investigation.",
"   </p>",
"   <p>",
"    Some patients unable to swallow the 600 mg tablet or 200 mg capsules may be able to swallow the smaller 50 or 100 mg capsules.",
"   </p>",
"   <p>",
"    Anecdotally, patients may find that opening these capsules and mixing the powder in applesauce may result in a hot pepper sensation; mixing the powder in sweet, low fat foods like jam may help to mask the peppery taste.",
"   </p>",
"   <p>",
"    Although there are no stability or pharmacokinetic data available, the manufacturer's suggestion for patients with nasogastric tubes is as follows: open the capsules (not the tablets) and grind the powder more finely in a mortar. Since it is practically insoluble in water, the drug must be mixed with 5 mL MCT oil (Captex) or 15 mL Orasweet and be given immediately.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     Efavirenz",
"    </a>",
"    should not be mixed with polyethylene glycol as it may decrease drug bioavailability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7854084\">",
"    <span class=\"h2\">",
"     Atripla (efavirenz-emtricitabine-tenofovir)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This coformulated tablet should not be crushed because plasma levels are not bioequivalent to levels achieved with the intact tablet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/5\">",
"     5",
"    </a>",
"    ]. For example, when crushed and dissolved in 5 mL of water, the area under the curve (AUC) for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    was 97 percent higher and the AUC for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    was 20 percent higher compared with swallowing the intact tablet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523034\">",
"    <span class=\"h2\">",
"     Rilpivirine (Edurant)",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no liquid formulation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15798?source=see_link\">",
"     rilpivirine",
"    </a>",
"    and there is not any pharmacologic information regarding dissolving or crushing the available 25 mg tablets.",
"   </p>",
"   <p>",
"    However, if the patient can swallow small pills,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15798?source=see_link\">",
"     rilpivirine",
"    </a>",
"    tablets are quite small (eg, slightly larger than an 81 mg",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    tablet). Pediatric and injectable formulations are under study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523041\">",
"    <span class=\"h2\">",
"     Rilpivirine-emtricitabine-tenofovir coformulation (Complera)",
"    </span>",
"    &nbsp;&mdash;&nbsp;No liquid is available for this coformulated product. See options regarding the individual components. (See",
"    <a class=\"local\" href=\"#H4522951\">",
"     'Tenofovir (Viread)'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4523034\">",
"     'Rilpivirine (Edurant)'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4523069\">",
"     'Emtricitabine (Emtriva)'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853561\">",
"    <span class=\"h2\">",
"     Etravirine (Intelence)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13320?source=see_link\">",
"     Etravirine",
"    </a>",
"    (Intelence) tablets (one 200 mg tablet or two 100 mg tablets per dose) are very large but can be dissolved in water (at least 5 mL) and taken in this form at the standard twice-daily dosing interval. After stirring the tablets in water, the solution will appear milky. At this point, more water, orange juice or milk may be added. However, warm, carbonated beverages and grapefruit juice should be avoided. The patient should be advised to ingest the solution immediately with food or following a meal, rinsing the glass with water several times and swallowing the rinse water to ensure that the complete dose is ingested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853675\">",
"    <span class=\"h2\">",
"     Nevirapine (Viramune, Viramune XR)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A white suspension of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/12/18633?source=see_link\">",
"     nevirapine",
"    </a>",
"    containing 50",
"    <span class=\"nowrap\">",
"     mg/5",
"    </span>",
"    mL is available in a 240 mL bottle, which should be shaken before each use. Nevirapine is one of the more palatable liquid formulations. The normal adult liquid dose that is equivalent to a 200 mg immediate-release tablet twice daily is 20 mL taken twice daily. As with the tablet formulation, the patient who is initiating nevirapine should receive 200 mg once daily for two weeks; if tolerated, nevirapine dosing frequency is increased to the standard immediate-release dosing of 200 mg twice daily. There is no liquid option for the 400 mg once-daily Viramune XR formulation.",
"   </p>",
"   <p>",
"    Because the side effect profile of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/12/18633?source=see_link\">",
"     nevirapine",
"    </a>",
"    includes serious hepatotoxicity, this agent is used as an alternative to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"     efavirenz",
"    </a>",
"    . Furthermore, nevirapine should not be given to women with CD4 counts &gt;250 and men with CD4 counts &gt;400",
"    <span class=\"nowrap\">",
"     mL/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    due to increased risk of toxicity in these patient populations. Unlike efavirenz, nevirapine can be used in pregnant women, providing that the baseline CD4 count is less than 250",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    at initiation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/18/37162?source=see_link&amp;anchor=H22#H22\">",
"     \"Pharmacology of non-nucleoside reverse transcriptase inhibitors\", section on 'Nevirapine (Viramune)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523084\">",
"    <span class=\"h1\">",
"     PROTEASE INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;First-line protease inhibitor agents include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/31/506?source=see_link\">",
"     atazanavir",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=see_link\">",
"     darunavir",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4523114\">",
"    <span class=\"h2\">",
"     Atazanavir (Reyataz)",
"    </span>",
"    &nbsp;&mdash;&nbsp;No liquid formulation is commercially available in the United States yet. However, the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/31/506?source=see_link\">",
"     atazanavir",
"    </a>",
"    capsules can be opened, mixed with four ounces of applesauce, and ingested immediately prior to a light meal. A pharmacokinetic study documented that the bioavailability of atazanavir administered in applesauce was 92 percent compared with ingestion of standard oral dose of two 200 mg capsules, both within five minutes of a light meal. Although the peak concentration was lower when the capsules were opened, the area under the curve for the two routes was similar [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/31/506?source=see_link\">",
"     Atazanavir",
"    </a>",
"    is usually given with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    ; however, the liquid formulation of ritonavir is usually found to be unpalatable by patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Darunavir (Prezista)",
"    </span>",
"    &nbsp;&mdash;&nbsp;A",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=see_link\">",
"     darunavir",
"    </a>",
"    oral suspension was approved by the US Food and Drug Administration (FDA) in December 2011, although there has been a delay in commercial availability.",
"   </p>",
"   <p>",
"    The 100",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    strawberry-flavored suspension of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=see_link\">",
"     darunavir",
"    </a>",
"    is produced in 200 mL bottles with a dosing syringe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/9\">",
"     9",
"    </a>",
"    ]. The dosing of liquid darunavir is the same as the tablets, which varies by history of HIV drug resistance mutations. For patients without any darunavir-associated mutations, 800 mg (8 mL) of darunavir is given once daily with food alone with 100 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    solution (1.25 mL) for pharmacokinetic boosting. In contrast, patients with one or more darunavir-associated mutations should take 600 mg (6 mL) twice daily with food and with ritonavir 100 mg (1.25 mL) twice daily.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=see_link\">",
"     Darunavir",
"    </a>",
"    MUST be administered with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    ; however, clinicians should be aware that patients often find the liquid formulation unpalatable.",
"   </p>",
"   <p>",
"    For patients in whom the size of the tablet is the main issue, there are smaller sized tablets:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      75 mg (0.36&rdquo; length by 0.17&rdquo; width by 0.16&rdquo; height)",
"     </li>",
"     <li>",
"      150 mg (0.54&rdquo; length by 0.27&rdquo; width by 0.17&rdquo; height)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These tablets are considerably smaller than the standard 400 mg tablet that is 0.75&rdquo; length by 0.37&rdquo; width by 0.22&rdquo; in height.",
"   </p>",
"   <p>",
"    The film-coated tablets are not sustained-release and, therefore, no specific bioavailability or release problems are anticipated if the tablets are crushed or dissolved in water. Although there are no pharmacokinetic studies to substantiate stability, bioavailability, and tolerability, preliminary data from case reports suggest clinical efficacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853592\">",
"    <span class=\"h2\">",
"     Fosamprenavir (Lexiva)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral suspension (50",
"    <span class=\"nowrap\">",
"     mg/mL)",
"    </span>",
"    of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/11/44217?source=see_link\">",
"     fosamprenavir",
"    </a>",
"    is off-white with a grape-bubblegum-peppermint flavor. It is available in 225 mL bottles and does not require reconstitution. It can be stored at 40 to 86&ordm;F, although refrigeration may improve palatability. It should be shaken well before using. Adults should take it without food, on an empty stomach, as food reduces the serum levels by 28 percent (area under the curve). As with the tablet, there are four different adult dose options. Note that when fosamprenavir is used in a",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    -boosted dose, patients must also ingest the relatively unpalatable ritonavir solution.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Antiretroviral-na&iuml;ve adult patients dosing options:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/11/44217?source=see_link\">",
"       Fosamprenavir",
"      </a>",
"      1400 mg (28 mL suspension) twice daily (without",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"       ritonavir",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/11/44217?source=see_link\">",
"       Fosamprenavir",
"      </a>",
"      1400 mg (28 mL suspension) once daily plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"       ritonavir",
"      </a>",
"      200 mg once daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/11/44217?source=see_link\">",
"       Fosamprenavir",
"      </a>",
"      1400 mg (28 mL suspension) once daily plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"       ritonavir",
"      </a>",
"      100 mg once daily",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/11/44217?source=see_link\">",
"       Fosamprenavir",
"      </a>",
"      700 mg (14 mL suspension) twice daily plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"       ritonavir",
"      </a>",
"      100 mg twice daily",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Protease inhibitor-experienced patients dosing:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Only one dose option is FDA-approved for protease inhibitor-experienced patients:",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/11/44217?source=see_link\">",
"       fosamprenavir",
"      </a>",
"      700 mg (14 mL suspension) twice daily plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"       ritonavir",
"      </a>",
"      100 mg twice daily.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853758\">",
"    <span class=\"h2\">",
"     Ritonavir (Norvir)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     Ritonavir",
"    </a>",
"    comes as an oral solution containing 80",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    in 240 mL bottles with a measuring cap. Refrigeration of the oral solution is not required.",
"   </p>",
"   <p>",
"    Unfortunately, many patients find this preparation unpalatable since it is oily, has a peppermint-caramel flavor, and contains 43 percent alcohol. However, the volume required for most adult patients is quite small (100",
"    <span class=\"nowrap\">",
"     mg/1.25",
"    </span>",
"    mL). Other strategies for making this palatable are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/32/40458?source=see_link\">",
"     \"HIV protease inhibitors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Lopinavir-ritonavir (Kaletra)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/57/20378?source=see_link\">",
"     Lopinavir-ritonavir",
"    </a>",
"    (Kaletra) is available in an oral solution containing 400 mg lopinavir and 100 mg",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    per 5 mL. This is equivalent to taking two of the tablets. The usual adult dose is 5 mL twice daily with food. Bottles are 160 mL and come with a calibrated dosing cup. However, Kaletra solution has a strong aftertaste that many patients find unpalatable. Coating the mouth and taste buds with Nutella, peanut butter, chocolate or peppermint candy may help, but other protease inhibitors are preferred, when feasible. It has a high alcohol and propylene glycol content, 42 percent and 15 percent, respectively.",
"   </p>",
"   <p>",
"    The tablets should not be chewed, broken, or crushed since ingestion of crushed tablets reduces bioavailability and absorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In addition, the tablet is film-coated, in part to mask lopinavir's very bitter taste. Most adults take two of the 200",
"    <span class=\"nowrap\">",
"     mg/50",
"    </span>",
"    mg tablets twice daily or four tablets once daily.",
"   </p>",
"   <p>",
"    For patients who find the 200 mg tablet difficult to swallow, a smaller 100",
"    <span class=\"nowrap\">",
"     mg/25",
"    </span>",
"    mg tab is also available. However, this would necessitate the patient taking a total of eight tablets a day, which increases pill burden.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853817\">",
"    <span class=\"h2\">",
"     Tipranavir (Aptivus)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/33/19992?source=see_link\">",
"     Tipranavir",
"    </a>",
"    is available in an oral solution, 100",
"    <span class=\"nowrap\">",
"     mg/mL.",
"    </span>",
"    The dosing is the same as the capsules, 500 mg (5 mL) twice daily plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/58/12202?source=see_link\">",
"     ritonavir",
"    </a>",
"    200 mg (2.5 mL) twice daily. It is a buttermint-toffee flavored liquid which comes in a 95 mL glass bottle with a 5 mL dosing syringe. It can be taken with or without food, should be stored at room temperature, and used within 60 days of opening. Tipranavir must be given with ritonavir although many patients find the ritonavir liquid unpalatable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37495/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853690\">",
"    <span class=\"h1\">",
"     INTEGRASE INHIBITORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Raltegravir (Isentress)",
"    </span>",
"    &nbsp;&mdash;&nbsp;No liquid formulation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/27/10678?source=see_link\">",
"     raltegravir",
"    </a>",
"    is available.",
"   </p>",
"   <p>",
"    Although there are no data on the stability, bioavailability or tolerability of the adult 400 mg",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/27/10678?source=see_link\">",
"     raltegravir",
"    </a>",
"    tablets when crushed, the film-coated tablets are not sustained release and are water-soluble so they can theoretically be crushed and dissolved in water.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/27/10678?source=see_link\">",
"     Raltegravir",
"    </a>",
"    pediatric chewable tablets were approved by the FDA in December 2011, although there was a delay in commercial availability. Unfortunately, this new pediatric chewable formulation is not bioequivalent to the adult 400 mg tablet and is therefore not recommended for use in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6536113\">",
"    <span class=\"h2\">",
"     Elvitegravir",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elvitegravir is a new integrase inhibitor currently only available as a component of a coformulation with cobicistat,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"     emtricitabine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"     tenofovir",
"    </a>",
"    (Stribild), approved by the FDA in 2012 as an alternative agent in antiretroviral-na&iuml;ve patients. There is no liquid formulation available for this combination product or for the individual components except for emtricitabine (see above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853864\">",
"    <span class=\"h1\">",
"     CCR5 INHIBITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     Maraviroc",
"    </a>",
"    is the only CCR5 inhibitor available to date. It is considered an alternative agent in the treatment of treatment-naive patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27994?source=see_link&amp;anchor=H7365544#H7365544\">",
"     \"Selection of antiretroviral therapy for the treatment-experienced patient with drug-resistant HIV infection\", section on 'CCR5 receptor antagonists'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853652\">",
"    <span class=\"h2\">",
"     Maraviroc (Selzentry)",
"    </span>",
"    &nbsp;&mdash;&nbsp;No liquid formulation is available for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"     maraviroc",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The tablets are film-coated and should be taken whole and not chewed or crushed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853879\">",
"    <span class=\"h1\">",
"     FUSION INHIBITORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7853530\">",
"    <span class=\"h2\">",
"     Enfuvirtide (Fuzeon, T20)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/2/7205?source=see_link\">",
"     Enfuvirtide",
"    </a>",
"    is only available in as a powder that is reconstituted into liquid form for subcutaneous administration. Because it is only stable for 24 hours after reconstitution, patients usually have to do the reconstitution steps themselves.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7854323\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antiretroviral therapy (ART) is recommended in all HIV-infected patients, regardless of CD4 cell count. However, some patients may have trouble taking combination regimens if they have difficulty swallowing due to other comorbidities. Fortunately, many antiretroviral medications are available as liquid preparations and some tablets can be crushed or dissolved. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Milligram dosing of a liquid preparation may differ from the milligram dose of a tablet formulation, so a direct conversion shouldn&rsquo;t be expected. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinician should instruct the patient to use a calibrated measuring device such as a plastic medication cup, medication spoon, or an oral syringe when measuring liquid antiretroviral medications and verify competency at dispensation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of HIV infection usually includes a backbone of two nucleoside reverse transcriptase inhibitors (NRTIs) plus a third agent from another drug class. First-line combination NRTI agents include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"       tenofovir",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"       emtricitabine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/63/31734?source=see_link\">",
"       abacavir",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/7/38007?source=see_link\">",
"       lamivudine",
"      </a>",
"      . Alternative liquid or powder formulations are available for these NRTIs, although coformulations are not. (See",
"      <a class=\"local\" href=\"#H4522885\">",
"       'Nucleoside reverse transcriptase inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no liquid or powder formulations for first-line agents, including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/42/29353?source=see_link\">",
"       efavirenz",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15798?source=see_link\">",
"       rilpivirine",
"      </a>",
"      , within the non-nucleoside reverse transcriptase inhibitor (NNRTI) class for the treatment-na&iuml;ve patient. A solution of an alternate NNRTI,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/12/18633?source=see_link\">",
"       nevirapine",
"      </a>",
"      , is available and is a therapeutic option among women with a CD4 cell count &lt;250 cells and among men with a CD4 cell count &lt;400",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"       .",
"      </span>",
"      The NNRTI,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13320?source=see_link\">",
"       etravirine",
"      </a>",
"      , is potent against wild-type and some drug-resistant strains of HIV and the tablets can be easily dissolved. (See",
"      <a class=\"local\" href=\"#H4522980\">",
"       'Non-nucleoside reverse transcriptase inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      First-line protease inhibitor agents include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/31/506?source=see_link\">",
"       atazanavir",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/39/36473?source=see_link\">",
"       darunavir",
"      </a>",
"      . No atazanavir liquid formulation is commercially available in the United States yet. However, atazanavir capsules can be opened, mixed with four ounces of applesauce, and ingested immediately prior to a light meal. A darunavir oral suspension was approved by the FDA at the end of 2011, although there has been a delay in commercial availability.",
"     </li>",
"     <li>",
"      No liquid formulations of the integrase inhibitors,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/27/10678?source=see_link\">",
"       raltegravir",
"      </a>",
"      or elvitegravir (coformulated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19191?source=see_link\">",
"       tenofovir",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/15/5366?source=see_link\">",
"       emtricitabine",
"      </a>",
"      , and cobicistat), are available for adults. (See",
"      <a class=\"local\" href=\"#H7853690\">",
"       'Integrase inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No liquid formulation is available for",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/45/20182?source=see_link\">",
"       maraviroc",
"      </a>",
"      , a CCR5 inhibitor. (See",
"      <a class=\"local\" href=\"#H7853864\">",
"       'CCR5 Inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?7/2/7205?source=see_link\">",
"       Enfuvirtide",
"      </a>",
"      is only available in a subcutaneous injection liquid formulation. (See",
"      <a class=\"local\" href=\"#H7853879\">",
"       'Fusion inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.aidsinfo.nih.gov/guidelines/ (Accessed on June 13, 2012).",
"    </li>",
"    <li>",
"     file://www.aidsinfo.nih.gov/guidelines/ (Accessed on June 29, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37495/abstract/3\">",
"      Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012; 308:387.",
"     </a>",
"    </li>",
"    <li>",
"     Tenofovir product labeling, Gilead Sciences, 2012.",
"    </li>",
"    <li>",
"     Bristol-Myers Squibb, 2011, personal communication.",
"    </li>",
"    <li>",
"     King J, et al. Assessment of Bioequivalence of Tenofovir, Emtricitabine, and Efavirenz Fixed-dose Combination Tablet Compared with a Compounded Oral Liquid Formulation Derived from the Tablet. 17th CROI, 16-19 February 2010, San Francisco. Poster abstract 605. file://www.retroconference.org/2010/Abstracts/37400.htm (Accessed on April 10, 2012).",
"    </li>",
"    <li>",
"     Etravirine product labeling, Tibotec Pharmaceuticals, March 2012.",
"    </li>",
"    <li>",
"     Data on file, BMS, 2012.",
"    </li>",
"    <li>",
"     Darunavir product labeling, Tibotec Therapeutics, December 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37495/abstract/10\">",
"      Scholten S, Mauruschat S, Hindermann S, Ranneberg B. Administration of darunavir tablets in patients with difficulties in swallowing - two case reports. J Int AIDS Soc 2010; 13(suppl 4):114.",
"     </a>",
"    </li>",
"    <li>",
"     Liu W, Klein CE, Marsh KC, et al. Predicted pharmacokinetics of lopinavir after multiple dose administration of lopinavir/ritonavir tablet to pediatric patients. Poster presented at the 8th International Conference on Drug Therapy in HIV Infection. November 12-16, 2006, Glasgow, UK. Abstract #366.",
"    </li>",
"    <li>",
"     Diep H, et al. Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children. 17th CROI, 16-19 February 2010, San Francisco. Poster abstract 877. file://www.retroconference.org/2010/Abstracts/37445.htm (Accessed on April 10, 2012).",
"    </li>",
"    <li>",
"     Tipranavir Product Labeling, Boehringer Ingelheim, 2012.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3763 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-71122602D8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37495=[""].join("\n");
var outline_f36_39_37495=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7854323\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      AVAILABILITY OF ALTERNATIVE FORMULATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4522885\">",
"      NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4522951\">",
"      Tenofovir (Viread)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4523069\">",
"      Emtricitabine (Emtriva)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853541\">",
"      Truvada (tenofovir-emtricitabine)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Abacavir (Ziagen)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4523179\">",
"      Lamivudine (Epivir, 3TC)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853848\">",
"      Zidovudine (Retrovir, ZDV, AZT)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4522930\">",
"      Combivir (zidovudine-lamivudine)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4522980\">",
"      NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4523010\">",
"      Efavirenz (Sustiva)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7854084\">",
"      Atripla (efavirenz-emtricitabine-tenofovir)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4523034\">",
"      Rilpivirine (Edurant)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4523041\">",
"      Rilpivirine-emtricitabine-tenofovir coformulation (Complera)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853561\">",
"      Etravirine (Intelence)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853675\">",
"      Nevirapine (Viramune, Viramune XR)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4523084\">",
"      PROTEASE INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4523114\">",
"      Atazanavir (Reyataz)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Darunavir (Prezista)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853592\">",
"      Fosamprenavir (Lexiva)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853758\">",
"      Ritonavir (Norvir)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Lopinavir-ritonavir (Kaletra)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853817\">",
"      Tipranavir (Aptivus)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7853690\">",
"      INTEGRASE INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Raltegravir (Isentress)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6536113\">",
"      Elvitegravir",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7853864\">",
"      CCR5 INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853652\">",
"      Maraviroc (Selzentry)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7853879\">",
"      FUSION INHIBITORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7853530\">",
"      Enfuvirtide (Fuzeon, T20)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7854323\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3763\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3763|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/19/25916\" title=\"table 1\">",
"      Liquid preparations of antiretroviral agents for adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21049?source=related_link\">",
"      Abacavir hypersensitivity reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/32/40458?source=related_link\">",
"      HIV protease inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/18/37162?source=related_link\">",
"      Pharmacology of non-nucleoside reverse transcriptase inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/26/34218?source=related_link\">",
"      Primer on interpretation of HIV drug resistance testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27994?source=related_link\">",
"      Selection of antiretroviral therapy for the treatment-experienced patient with drug-resistant HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/14/34024?source=related_link\">",
"      Treatment of drug-resistant genital herpes simplex virus infection in HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_39_37496="Serum thyroglobulin in the management of differentiated thyroid cancer";
var content_f36_39_37496=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Serum thyroglobulin in the management of differentiated thyroid cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37496/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37496/contributors\">",
"     R Michael Tuttle, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37496/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37496/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37496/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/39/37496/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/39/37496/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/39/37496/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroglobulin (Tg) is a prohormone of thyroxine (T4) and triiodothyronine (T3). It is synthesized only by thyroid follicular cells and released into serum along with the thyroid hormones. Given the cellular specificity of Tg, its detection in biopsy specimens provides proof of the thyroid origin of the tissue. In addition, measurements of serum Tg provide important information about the presence or absence of residual, recurrent, or metastatic disease in patients with differentiated thyroid cancer. This topic review will describe the methods for measuring serum Tg and the use of serum Tg measurements in patients with differentiated thyroid cancer. Other aspects of the management of thyroid cancer are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44313?source=see_link\">",
"     \"Overview of the management of differentiated thyroid cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THYROGLOBULIN ASSAY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Methodology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum Tg is now generally measured by two-antibody \"sandwich\" immunometric assays (the antigen is sandwiched between the two antibodies) in which the capture antibody is bound to a solid support and the detection antibody is labeled with either an isotopic (immunoradiometric assay, IRMA) or non-isotopic (usually immuno-chemiluminescent assay, ICMA) marker. The values in normal subjects in most laboratories range from 1 to about 30",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    These immunometric assays are quicker, readily automated, and have greater sensitivity (0.1 to 1",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    than most radioimmunoassays [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Interassay variation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite a trend toward assay standardization, serum Tg values obtained with different assays cannot be directly compared, as interassay variability remains substantial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The variability in assay results is due to [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/1,5-7\">",
"     1,5-7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Variations in the antithyroglobulin antibodies used.",
"     </li>",
"     <li>",
"      The heterogeneity of Tg, a consequence of alternative processing and differences in iodination of Tg.",
"     </li>",
"     <li>",
"      Thyroglobulin produced by thyroid cancer cells can be even more heterogeneous (because of dysregulation of the enzymatic glycosylation and iodination within malignant thyroid cells) and occasionally has enough conformational difference that it may not be recognized by a standard Tg assay.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The net effect can be widely variable antigen (Tg) detection among different assays. Therefore, we recommend that serial Tg measurements in thyroid cancer patients be done using the same assay.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Intraassay variation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even using the same assay, between run variability can affect the comparability of serial determinations over time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. While these differences are far less than the between-assay differences, they can be responsible for small fluctuations in Tg measurements over time within the same patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Functional sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional sensitivity is defined as the lowest Tg concentration that an assay can reliably and consistently measure under clinically relevant conditions with less than 20 percent coefficient of variation. For many years, the functional sensitivity of most Tg assays had been about 0.9",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    However, several assays with functional sensitivities of 0.2",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    or slightly lower have become commercially available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To further enhance the sensitivity of serum Tg in the detection of",
"    <span class=\"nowrap\">",
"     persistent/recurrent",
"    </span>",
"    thyroid cancer, serum Tg levels are often measured during TSH stimulation (either thyroid hormone withdrawal or with recombinant human TSH [rhTSH] administration). When using the less sensitive assays (functional sensitivities of approximately 1",
"    <span class=\"nowrap\">",
"     ng/mL),",
"    </span>",
"    TSH stimulation will result in a previously undetectable serum Tg value becoming measurable in as many as 20 to 25 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The newer, more sensitive Tg assays may decrease the need for rhTSH-stimulated measurements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/4,10-12\">",
"     4,10-12",
"    </a>",
"    ]. This was illustrated in a study of 178 low-risk patients, 130 of whom had a serum thyroglobulin &lt;0.1",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    After withdrawal of thyroid hormone, 5 of 130 (3.8 percent) had a thyroglobulin &gt;1",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    and recurrence was diagnosed in only one patient. Among the 48 patients with thyroglobulin &gt;0.1",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    42 percent had thyroglobulin &gt;1",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    after withdrawal and 11 percent had recurrences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hook effect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, immunometric assays may fail to detect very high serum Tg concentrations due to the so-called \"hook effect,\" in which extremely high concentrations of Tg bind to each antibody, preventing the formation of the two-antibody sandwich upon which the assay depends [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/13\">",
"     13",
"    </a>",
"    ]. If this effect is suspected, the sample should be reanalyzed after dilution to obtain a reliable Tg measurement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Thyroglobulin mRNA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of sensitive polymerase chain reaction (RT-PCR) methods allows the detection of Tg messenger RNA circulating in the peripheral blood of patients with thyroid cancer, presumably contained within circulating tumor cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. The immediate advantage of such an assay would be bypassing the problem of interference of antithyroglobulin autoantibodies in the Tg assays. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Anti-Tg antibodies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    An assay for circulating TSH receptor-mRNA by RT-PCR appears to have similar sensitivity and specificity to that reported for Tg mRNA assays [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/17,18\">",
"     17,18",
"    </a>",
"    ], and may be useful as soon as one day following initial thyroid surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical utility of these messenger RNA based assays remains uncertain. Furthermore, they are not commercially available at this time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ANTI-Tg ANTIBODIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-thyroglobulin antibodies are detectable in as many as 10 percent of the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/20\">",
"     20",
"    </a>",
"    ] and 20 percent of thyroid cancer patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/1,21\">",
"     1,21",
"    </a>",
"    ]. These antibodies represent a challenge, because Tg values obtained in the presence of anti-Tg antibodies may not be clinically reliable. Therefore, we recommend measuring antithyroglobulin antibodies using the same assay over time with each measurement of serum thyroglobulin.",
"   </p>",
"   <p>",
"    Although the pathophysiologic importance of these antibodies after total thyroidectomy is unclear, their persistence for more than one year after thyroidectomy and radioiodine ablation probably indicates the presence of residual thyroid tissue, and possibly an increased risk of recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/21\">",
"     21",
"    </a>",
"    ]. As an example, in two studies of thyroid cancer patients with undetectable serum Tg concentrations, 18 and 49 percent of patients with serum anti-Tg antibody concentrations &gt;100",
"    <span class=\"nowrap\">",
"     U/mL",
"    </span>",
"    had a recurrence, compared with only 1 and 3 percent of patients with serum anti-Tg antibody concentrations &lt;100",
"    <span class=\"nowrap\">",
"     U/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. No patients whose anti-Tg antibody titer fell by more than 50 percent within a year of remnant ablation had a recurrence, while 37 percent whose anti-Tg antibody titers increased had a recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with co-existent autoimmune thyroid disease at the time of surgery, anti-Tg antibodies may persist far longer. In a study of 116 patients with anti-Tg antibodies prior to thyroidectomy, antibodies remained detectable for up to 20 years in some patients without detectable thyroid tissue, and the median time to disappearance of antibodies was three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Impact on TG assay",
"    </span>",
"    &nbsp;&mdash;&nbsp;By binding with the circulating serum Tg, anti-thyroglobulin antibodies may decrease the amount of unbound (free) Tg available for detection. Since immunometric assay systems appear to detect only the unbound (free) Tg, this effect can result in falsely low values. The magnitude of the interference is most noticeable at low Tg levels where the immunometric assays can falsely report an undetectable serum Tg if the anti-Tg antibodies are competing for the low level circulating Tg molecules. This effect is not abrogated by use of monoclonal antibodies directed against epitopes of Tg that do not react with the autoantibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/25\">",
"     25",
"    </a>",
"    ]. Even very low anti-thyroglobulin antibody levels can interfere with the Tg assay performance. There does not appear to be a threshold value of anti-Tg antibodies that is predictive of antibody interference [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/1\">",
"     1",
"    </a>",
"    ]. In some antithyroglobulin antibody assays, more reliable results are obtained if any level above the analytic sensitivity of the assay is considered to be Tg antibody positive rather than using the manufacturer recommended cut-off levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conversely, radioimmunoassays tend to report falsely high Tg values. This is probably because, unlike the immunometric assay, the radioimmunoassay detects both unbound (free) Tg and bound Tg (complexed to anti-Tg antibodies). As a result, the Tg value reported may be higher than the actual \"free\" thyroglobulin circulating in the blood stream, but is much less likely to be false low value. Because of this discordance between radioimmunoassay and immunometric assays, some authors have recommended that in the presence of anti-Tg antibodies, radioimmunoassays should be used to measure the serum Tg (recognizing the possibility of a false high result) but assuming a low value is likely to be real and reflect the clinical situation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/27\">",
"     27",
"    </a>",
"    ]. While this approach appears to be valid, radioimmunoassays are not widely available and still need to be interpreted with caution.",
"   </p>",
"   <p>",
"    In an attempt to determine whether a circulating anti-Tg antibody is causing assay interference, several commercial labs offer Tg measurements by recovery assays, using standard immunometric assays to determine serum Tg levels before and after addition of known amount of thyroglobulin. If 80 to 120 percent of the added quantity of Tg is detected, the antibodies are not considered to be interfering and a Tg value is reported. If the value falls outside that range, antibody interference is assumed and no Tg value is reported. While these assays have gained popularity in both the US and Europe, many experts feel strongly that recovery assays are not reliable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because anti-Tg antibodies can have a major impact on the measurement of serum Tg, all laboratories that measure serum Tg should test for anti-Tg antibodies in any serum sample submitted for Tg assay. Even in patients previously documented to be free of anti-Tg antibodies, disease recurrence can be heralded by a rise in Tg antibodies with or without a corresponding rise in serum Tg. As noted, the level of anti-thyroglobulin antibodies can serve as a surrogate tumor marker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/22,27\">",
"     22,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following total thyroidectomy and RAI ablation, serum anti-Tg antibodies usually fall to undetectable levels over three to five years while patients with persistent disease typically maintain detectable or rising anti-Tg antibodies. Just as with serum Tg measurements, anti-Tg antibody levels are dependent upon the assay used, and serial values need to be compared within the same assay.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Heterophilic antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;False positive Tg results have been reported as a result of interference by heterophilic anti-mouse antibodies (HAMA) in an immunometric assay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/28\">",
"     28",
"    </a>",
"    ]. In this report, about 3 percent of the 1100 blood specimens tested had substantial differences in the measured Tg value before and after the specimens were treated to block potential heterophile antibody interference.",
"   </p>",
"   <p>",
"    While an uncommon clinical problem, the presence of HAMA antibody interference should be considered in patients in whom an elevated Tg does not seem appropriate for their clinical condition. Since radioimmunoassay is very unlikely to be affected by HAMA antibodies, repeat determination with a radioimmunoassay technique is likely to reveal the true serum Tg level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three major determinants of the serum Tg concentration are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mass of thyroid tissue present (both normal and malignant thyroid cells)",
"     </li>",
"     <li>",
"      The presence of injury to the thyroid (eg, after fine needle aspiration, thyroidectomy or radioactive iodine therapy, or during thyroiditis)",
"     </li>",
"     <li>",
"      The degree of TSH receptor stimulation (eg, endogenous TSH, recombinant human TSH, serum HCG, TSH receptor antibodies associated with autoimmune thyroid disease)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with metastatic thyroid cancer, the serum Tg appears to be influenced by the volume of disease, the specific histology of the lesion, and the anatomic location of the metastasis. As an example, in a retrospective study of 417 thyroid cancer patients, basal thyroglobulin concentrations correlated with the volume and location of metastases (higher with bone",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lung than cervical metastases), and with the histological type of cancer (higher levels in follicular and H&uuml;rthle cell cancers compared to papillary cancers) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/29\">",
"     29",
"    </a>",
"    ]. Stimulated thyroglobulin concentrations (in response to recombinant TSH) correlated only with histological type of cancer (highest in papillary and lowest in H&uuml;rthle cell cancers).",
"   </p>",
"   <p>",
"    An important caveat pertains to patients in whom rhTSH is used for remnant ablation. In that protocol, radioiodine is given 48 hours before the measurement of the \"stimulated\" Tg, which may cause release of Tg from the remnants, potentially causing spuriously higher values [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44313?source=see_link&amp;anchor=H17#H17\">",
"     \"Overview of the management of differentiated thyroid cancer\", section on 'Long-term follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Marker of persistent disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum TG measurements are useful for detecting persistent disease. A meta-analysis found that the sensitivity and specificity of thyroglobulin measurement to detect persistent thyroid cancer was 96 and 95 percent, respectively, after thyroid hormone withdrawal, and 93 and 88 percent, respectively, after rhTSH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/31\">",
"     31",
"    </a>",
"    ]. However, combining rhTSH stimulation with cervical ultrasound improved sensitivity and negative predictive value to 93 and 99 percent, respectively, in a study of 340 consecutive patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Repeat rhTSH-stimulated Tg testing in patients whose first stimulated Tg is undetectable may not be useful. As an example, in one study of 68 patients with a recombinant human TSH stimulated thyroglobulin that was initially &lt;1",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    at the time of remnant ablation, only 1 of 67 patients had a detectable stimulated value two to three years later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Detecting recurrent thyroid cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because serum Tg concentration is dependent on the mass of thyroid tissue present (both normal and malignant), serum Tg values have the highest sensitivity and specificity for detection of recurrent disease after the patient has had a total thyroidectomy and RAI ablation of any microscopic residual normal thyroid cells remaining after total thyroidectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Serum thyroglobulin measured before thyroidectomy is a reflection of both the normal and malignant thyroid cells and therefore is not a reliable predictor of thyroid cancer. Serum thyroglobulin is cleared with a half-life of about 30 hours following thyroidectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/37\">",
"     37",
"    </a>",
"    ]. After total thyroidectomy and RAI ablation, serum Tg levels would be expected to be undetectable if the patient is cured [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/38\">",
"     38",
"    </a>",
"    ], although it may take up to one year or longer for this to occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, since Tg production and release from the cell are significantly influenced by the degree of TSH stimulation, it is not surprising that Tg measurements are likely to be more sensitive for detection of recurrent disease following TSH stimulation (endogenous TSH or rhTSH) than when measured during TSH suppression (on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    While we recommend that thyroglobulin be measured after recombinant human TSH at one year in stage I or II patients, others have utilized T4-suppressed thyroglobulin measurements along with ultrasound.",
"   </p>",
"   <p>",
"    In one such study of 495 patients, a detectable thyroglobulin while taking thyroxine indicated recurrence in 23 of 44 patients, while the addition of ultrasound detected 42 of the 44 recurrences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Predictor of clinical outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum Tg concentrations may predict disease-free remission at various times in the patient's course [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/40\">",
"     40",
"    </a>",
"    ]. As an example, in a study of 366 patients, pre-ablation serum Tg &gt;27",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    had an 88 percent sensitivity and 90 percent specificity for the presence of tumor; six months after initial remnant ablation a TSH-stimulated serum Tg &gt;10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    had a sensitivity of 100 percent and a specificity of 93 percent; two years after initial therapy while on",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    suppression a serum Tg &gt;2",
"    <span class=\"nowrap\">",
"     ng/L",
"    </span>",
"    had a sensitivity of 85 percent and a specificity of 86 percent for the presence of tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study that assessed Tg levels months after remnant ablation and with up to five years of follow-up, recurrent tumor was identified in 1.6 percent of patients with initial Tg after rhTSH under 0.5",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    5.5 percent of patients with Tg 0.6 to 2.0",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    and 80 percent of patients with Tg greater than 2.0",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The serum Tg concentration in low risk patients after initial surgery while hypothyroid, just prior to administration of RAI for remnant ablation, has been correlated with the subsequent clinical course. In one report, patients with Tg &gt;2",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    demonstrated 23 percent clinical recurrence, 36 percent persistent Tg elevation without apparent disease, and 41 percent complete remission, while those with Tg &lt;2",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    demonstrated 2 percent clinical recurrence, 17 percent persistent Tg elevation, and 81 percent complete remission [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has become increasingly apparent that the results of repeated measurements of serum Tg over time are often more useful than a single measurement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. A progressive increase in serum Tg concentrations strongly suggests progressive disease, and should lead to a search for the disease, usually starting with a chest x-ray, neck ultrasonography, and radioiodine scanning. Serum Tg doubling time of less than one year was associated with significantly higher rates of 10-year disease-specific mortality, loco-regional metastases, and identification of distant metastases than Tg doubling times of one to three years or greater than three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     High serum Tg and negative radioiodine scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients who have a high serum Tg concentration while taking T4 after primary surgery and radioiodine ablation of the thyroid remnant, about 15 percent have diagnostic whole-body radioiodine scans that are normal, ie, no detectable uptake anywhere [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. These false-negative scans may reflect inadequate TSH stimulation, iodine contamination, the presence of tumor deposits too small to be detected by a scintillation camera, or loss of iodine uptake through tumor dedifferentiation.",
"   </p>",
"   <p>",
"    After administration of a high dose of radioiodine (eg, 150 mCi [5550 MBq]), 42 to 75 percent of these patients in studies had demonstrable uptake, most often in the neck and mediastinum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. Distant metastases were more often identified in patients with higher serum Tg concentrations (&gt;200",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/50\">",
"     50",
"    </a>",
"    ]. In another study, only 17 percent of patients had uptake after a high dose of radioiodine, but only 8 percent had uptake in metastases, and none benefited from treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other imaging tests, such as ultrasonography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/49,53\">",
"     49,53",
"    </a>",
"    ], computed tomography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/49\">",
"     49",
"    </a>",
"    ], magnetic resonance imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/54\">",
"     54",
"    </a>",
"    ], or scintigraphy with 111-indium-penetreotide, 99m-technetium-sestamibi or 99m-technetium-tetrafosmin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/55-57\">",
"     55-57",
"    </a>",
"    ], detect foci of cancer in from 25 to 50 percent of patients with negative diagnostic radioiodine scans; some of these foci may be amenable to surgical resection that can render patients' Tg levels undetectable in 25 to 50 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/49,58\">",
"     49,58",
"    </a>",
"    ]. Distant metastases can also be identified by chest and bone radiographs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with serum Tg &gt;10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    and a negative radioiodine scan, [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography (PET) may be useful. In a review of PET imaging in scan-negative patients that summarized 12 studies, sensitivity ranged from 60 to 95 percent and specificity from 25 to 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/60\">",
"     60",
"    </a>",
"    ]. Metastatic lesions with high avidity for glucose in PET imaging, measured by elevated standard uptake values, are associated with resistance to radioiodine therapy and worse prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/47,50,51,63\">",
"     47,50,51,63",
"    </a>",
"    ] but not all [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/64\">",
"     64",
"    </a>",
"    ] studies, radioiodine administration resulted in reductions in serum Tg concentrations, but there is no evidence that the treatment affects prognosis. Furthermore, when there is no structural evidence of disease, observation with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"     levothyroxine",
"    </a>",
"    suppression is often associated with a slow decline in Tg levels over many years. These observations question whether empiric RAI therapy for scan negative, Tg positive patients has any significant clinical benefit beyond improved disease localization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/39/37496/abstract/27,58,65,66\">",
"     27,58,65,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Suggested approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend the following approach to patients with radioiodine negative, Tg positive disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measurement of 24-hour urinary iodine excretion to exclude exogenous iodine excess causing a false-negative scan.",
"     </li>",
"     <li>",
"      Neck ultrasound and chest CT (without iodinated contrast).",
"     </li>",
"     <li>",
"      In low-risk patients with stimulated Tg &lt;10",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      who do not have surgically resectable disease in the central neck region, we suggest continued TSH suppressive thyroid hormone therapy and observation.",
"     </li>",
"     <li>",
"      In high risk patients or those whose stimulated Tg is at least 10",
"      <span class=\"nowrap\">",
"       ng/mL,",
"      </span>",
"      additional imaging studies should be performed to include whole body 18FDG PET scan (preferably combined with CT imaging). We suggest radioiodine administration (100 to 200 mCi) in patients with radiographically detectable micrometastatic pulmonary metastases that do not concentrate 18FDG on PET imaging or with progressively rising Tg levels. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34010?source=see_link\">",
"       \"Radioiodine treatment of differentiated thyroid cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      External radiotherapy for patients with critically placed bone metastases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/17/39191?source=see_link\">",
"       \"External beam radiotherapy in the treatment of thyroid cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with progressive macrometastatic disease unresponsive to radioiodine should be considered for systemic therapy or an appropriate clinical trial.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    Thyroglobulin (Tg) is a prohormone of thyroxine (T4) and triiodothyronine (T3). It is synthesized only by thyroid follicular cells and released into serum along with the thyroid hormones. Given the cellular specificity of Tg, its detection in biopsy specimens provides proof of the thyroid origin of the tissue.",
"   </p>",
"   <p>",
"    Limitations to serum thyroglobulin assays include interassay variability and the high prevalence of antithyroglobulin antibodies, which may interfere with Tg assay results. However, in spite of these limitations, measurements of serum Tg provide important information about the presence or absence of residual, recurrent, or metastatic disease in patients with differentiated thyroid cancer.",
"   </p>",
"   <p>",
"    For patients with differentiated thyroid cancer who have undergone surgery and thyroid remnant ablation, we suggest measurement of serum thyroglobulin every 6 to 12 months to detect persistent or metastatic disease.",
"   </p>",
"   <p>",
"    Testing should be done using a sensitive assay, ideally using the same assay for each sample. Thyroglobulin antibodies should be measured with each sample.",
"   </p>",
"   <p>",
"    A suggested schedule for long-term monitoring, including serum thyroglobulin measurements, is found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44313?source=see_link&amp;anchor=H17#H17\">",
"     \"Overview of the management of differentiated thyroid cancer\", section on 'Long-term follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     High serum Tg with negative scan",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In low-risk patients with stimulated Tg &lt;10",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      who do not have surgically resectable disease in the central neck region, we suggest continued TSH suppressive thyroid hormone therapy and observation.",
"     </li>",
"     <li>",
"      We suggest radioiodine administration (100 to 200 mCi) in patients with radiographically detectable micrometastatic pulmonary metastases that do not concentrate 18FDG on PET imaging or in patients with progressively rising Tg levels.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/1\">",
"      Spencer CA, Bergoglio LM, Kazarosyan M, et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005; 90:5566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/2\">",
"      Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996; 42:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/3\">",
"      Weightman DR, Mallick UK, Fenwick JD, Perros P. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up. Cancer 2003; 98:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/4\">",
"      Schlumberger M, Hitzel A, Toubert ME, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007; 92:2487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/5\">",
"      Schulz R, Beth&auml;user H, Stempka L, et al. Evidence for immunological differences between circulating and thyroid tissue-derived thyroglobulin in men. Eur J Clin Invest 1989; 19:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/6\">",
"      Bertaux F, Noel M, Malthi&eacute;ry Y, Fragu P. Demonstration of a heterogeneous transcription pattern of thyroglobulin mRNA in human thyroid tissues. Biochem Biophys Res Commun 1991; 178:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/7\">",
"      Sinadinovi�� J, Cveji�� D, Savin S, et al. Altered terminal glycosylation of thyroglobulin in papillary thyroid carcinoma. Exp Clin Endocrinol 1992; 100:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/8\">",
"      Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf) 2003; 58:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/9\">",
"      Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/10\">",
"      Smallridge RC, Meek SE, Morgan MA, et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 2007; 92:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/11\">",
"      Iervasi A, Iervasi G, Ferdeghini M, et al. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf) 2007; 67:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/12\">",
"      Rosario PW, Purisch S. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 &lt; 1 ng/ml determined by traditional assays? Clin Endocrinol (Oxf) 2008; 68:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/13\">",
"      Cole TG, Johnson D, Eveland BJ, Nahm MH. Cost-effective method for detection of \"hook effect\" in tumor marker immunometric assays. Clin Chem 1993; 39:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/14\">",
"      Grammatopoulos D, Elliott Y, Smith SC, et al. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer. Mol Pathol 2003; 56:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/15\">",
"      Elisei R, Vivaldi A, Agate L, et al. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab 2004; 89:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/16\">",
"      Fugazzola L, Mihalich A, Persani L, et al. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission. J Clin Endocrinol Metab 2002; 87:3201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/17\">",
"      Chinnappa P, Taguba L, Arciaga R, et al. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. J Clin Endocrinol Metab 2004; 89:3705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/18\">",
"      Gupta M, Chia SY. Circulating thyroid cancer markers. Curr Opin Endocrinol Diabetes Obes 2007; 14:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/19\">",
"      Chia SY, Milas M, Reddy SK, et al. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer. J Clin Endocrinol Metab 2007; 92:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/20\">",
"      Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/21\">",
"      Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/22\">",
"      Chung JK, Park YJ, Kim TY, et al. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 2002; 57:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/23\">",
"      Kim WG, Yoon JH, Kim WB, et al. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2008; 93:4683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/24\">",
"      Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003; 139:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/25\">",
"      Piechaczyk M, Baldet L, Pau B, Bastide JM. Novel immunoradiometric assay of thyroglobulin in serum with use of monoclonal antibodies selected for lack of cross-reactivity with autoantibodies. Clin Chem 1989; 35:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/26\">",
"      Spencer C, Petrovic I, Fatemi S. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 2011; 96:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/27\">",
"      Spencer CA, Lopresti JS. Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 2008; 4:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/28\">",
"      Preissner CM, O'Kane DJ, Singh RJ, et al. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 2003; 88:3069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/29\">",
"      Robbins RJ, Srivastava S, Shaha A, et al. Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. J Clin Endocrinol Metab 2004; 89:6010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/30\">",
"      Ta&iuml;eb D, Lussato D, Guedj E, et al. Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy. Thyroid 2006; 16:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/31\">",
"      Eustatia-Rutten CF, Smit JW, Romijn JA, et al. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf) 2004; 61:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/32\">",
"      Pacini F, Molinaro E, Castagna MG, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003; 88:3668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/33\">",
"      Castagna MG, Brilli L, Pilli T, et al. Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J Clin Endocrinol Metab 2008; 93:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/34\">",
"      Ozata M, Suzuki S, Miyamoto T, et al. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994; 79:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/35\">",
"      Lo Gerfo P, Colacchio TA, Colacchio DA, Feind CR. Effect of TSH stimulation on serum thyroglobulin in metastatic thyroid cancer. J Surg Oncol 1980; 14:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/36\">",
"      Pacini F, Lari R, Mazzeo S, et al. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 1985; 23:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/37\">",
"      Giovanella L, Ceriani L, Maffioli M. Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma. Head Neck 2010; 32:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/38\">",
"      Spencer CA, Wang CC. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 1995; 24:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/39\">",
"      Pelttari H, Laitinen K, Schalin-J&auml;ntti C, V&auml;lim&auml;ki MJ. Long-term outcome of 495 TNM stage I or II patients with differentiated thyroid carcinoma followed up with neck ultrasonography and thyroglobulin measurements on T4 treatment. Clin Endocrinol (Oxf) 2008; 69:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/40\">",
"      Baudin E, Do Cao C, Cailleux AF, et al. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 2003; 88:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/41\">",
"      Heemstra KA, Liu YY, Stokkel M, et al. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 2007; 66:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/42\">",
"      Kloos RT, Mazzaferri EL. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 2005; 90:5047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/43\">",
"      Kim TY, Kim WB, Kim ES, et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2005; 90:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/44\">",
"      Black EG, Sheppard MC, Hoffenberg R. Serial serum thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 1987; 27:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/45\">",
"      Huang SH, Wang PW, Huang YE, et al. Sequential follow-up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis. Thyroid 2006; 16:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/46\">",
"      Miyauchi A, Kudo T, Miya A, et al. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. Thyroid 2011; 21:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/47\">",
"      Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987; 28:1888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/48\">",
"      Schlumberger M, Arcangioli O, Piekarski JD, et al. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988; 29:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/49\">",
"      Pachucki J, Burmeister LA. Evaluation and treatment of persistent thyroglobulinemia in patients with well-differentiated thyroid cancer. Eur J Endocrinol 1997; 137:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/50\">",
"      Pineda JD, Lee T, Ain K, et al. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995; 80:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/51\">",
"      Koh JM, Kim ES, Ryu JS, et al. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study. Clin Endocrinol (Oxf) 2003; 58:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/52\">",
"      Fatourechi V, Hay ID, Javedan H, et al. Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer. J Clin Endocrinol Metab 2002; 87:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/53\">",
"      Franceschi M, Kusi�� Z, Franceschi D, et al. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1996; 37:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/54\">",
"      Toubert ME, Cyna-Gorse F, Zagdanski AM, et al. Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: clinical use and limits. Thyroid 1999; 9:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/55\">",
"      Lind P, Gallowitsch HJ, Langsteger W, et al. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med 1997; 38:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/56\">",
"      Baudin E, Schlumberger M, Lumbroso J, et al. Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. J Clin Endocrinol Metab 1996; 81:2541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/57\">",
"      Valli N, Catargi B, Ronci N, et al. Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy. Thyroid 1999; 9:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/58\">",
"      Alzahrani AS, Raef H, Sultan A, et al. Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer. J Endocrinol Invest 2002; 25:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/59\">",
"      Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/60\">",
"      Khan N, Oriuchi N, Higuchi T, et al. PET in the follow-up of differentiated thyroid cancer. Br J Radiol 2003; 76:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/61\">",
"      Wang W, Larson SM, Fazzari M, et al. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 2000; 85:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/62\">",
"      Wang W, Larson SM, Tuttle RM, et al. Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. Thyroid 2001; 11:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/63\">",
"      Pacini F, Agate L, Elisei R, et al. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. J Clin Endocrinol Metab 2001; 86:4092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/64\">",
"      Schaap J, Eustatia-Rutten CF, Stokkel M, et al. Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma? Clin Endocrinol (Oxf) 2002; 57:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/65\">",
"      Pacini F, Capezzone M, Elisei R, et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002; 87:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/39/37496/abstract/66\">",
"      Ma C, Kuang A, Xie J. Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases. Cochrane Database Syst Rev 2009; :CD006988.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2193 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-EA571C30FB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37496=[""].join("\n");
var outline_f36_39_37496=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THYROGLOBULIN ASSAY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Methodology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Interassay variation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Intraassay variation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Functional sensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hook effect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Thyroglobulin mRNA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ANTI-Tg ANTIBODIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Impact on TG assay",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Heterophilic antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL APPLICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Marker of persistent disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Detecting recurrent thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Predictor of clinical outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      High serum Tg and negative radioiodine scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Suggested approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      High serum Tg with negative scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/17/39191?source=related_link\">",
"      External beam radiotherapy in the treatment of thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44313?source=related_link\">",
"      Overview of the management of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34010?source=related_link\">",
"      Radioiodine treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_39_37497="Cutaneous changes of Stevens Johnson Syndrome";
var content_f36_39_37497=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F67632%7EDERM%2F68458%7EDERM%2F59418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F67632%7EDERM%2F68458%7EDERM%2F59418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cutaneous changes of Stevens-Johnson Syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 364px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Generalized eruption of lesions that initially had a target-like appearance but then became confluent, brightly erythematous, and bullous. The patient had extensive mucous membrane involvement and tracheobronchitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. In: Color Atlas and Synopsis of Clinical Dermatology: Common and Serious Diseases, 3rd edition, Fitzpatrick TB, Johnson RA, Wolff K, et al (Eds), McGraw-Hill, New York 1997. Copyright &copy; 1997 McGraw-Hill.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Toxic epidermal necrolysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse erythema and large areas of desquamation are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Toxic epidermal necrolysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple bullae and large areas of desquamation are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37497=[""].join("\n");
var outline_f36_39_37497=null;
var title_f36_39_37498="Asthma action plan";
var content_f36_39_37498=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 628px\">",
"   <div class=\"ttl\">",
"    Asthma action plan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 608px; height: 788px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37498=[""].join("\n");
var outline_f36_39_37498=null;
var title_f36_39_37499="Negative symptoms in schizophrenia";
var content_f36_39_37499=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F81542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F81542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Negative symptoms in schizophrenia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Negative symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        As manifested by:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"6\">",
"        Affective flattening",
"       </td>",
"       <td>",
"        Unchanging facial expression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Little spontaneous movement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Little use of expressive gestures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poor eye contact",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Affective non-responsivity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of vocal inflections",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Alogia",
"       </td>",
"       <td>",
"        Poverty of speech",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thought blocking",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased latency of response",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Apathy",
"       </td>",
"       <td>",
"        Poor grooming and hygiene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Failure of appropriate role responsibilities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anergy",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Asociality/anhedonia",
"       </td>",
"       <td>",
"        Failure to engage with peers socially",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No interest in stimulating activities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Little interest in sex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Little to no intimacy with others",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Andreasen NC. Negative symptoms in schizophrenia: Definition and reliability. Arch Gen Psychiatry 1982; 39:784. Copyright &copy; 1982 American Medical Association. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37499=[""].join("\n");
var outline_f36_39_37499=null;
var title_f36_39_37500="EEG predictors of epilepsy";
var content_f36_39_37500=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F78039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F78039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Spike location and probability of epilepsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Probability:",
"      </td>",
"      <td class=\"subtitle1\">",
"       Most often associated with:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       High probability of epilepsy (&gt;85 percent):",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Anterior-mid temporal spikes*",
"      </td>",
"      <td>",
"       Mesial temporal lobe epilepsy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Midline spikes&bull;",
"      </td>",
"      <td>",
"       Tonic-clonic seizures",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hypsarrhythmia",
"      </td>",
"      <td>",
"       Infantile spasms (West syndrome)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Slow spike-wave",
"      </td>",
"      <td>",
"       Lennox-Gastaut Syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Generalized paroxysmal fast activity",
"      </td>",
"      <td>",
"       Lennox-Gastaut Syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Moderate probability of epilepsy (&lt;75 percent):",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Frontal spikes&Delta;",
"      </td>",
"      <td>",
"       Frontal lobe epilepsy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Generalized spike-wave (&ge;3 Hz)",
"      </td>",
"      <td>",
"       Absence epilepsy (3 Hz; CAE, JAE), juvenile myoclonic epilepsy (&gt;3 Hz), and other primary generalized epilepsies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Centro-temporal spikes&loz;",
"      </td>",
"      <td>",
"       Benign rolandic epilepsy of childhoood (BREC)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Occipital spikes&sect;",
"      </td>",
"      <td>",
"       Benign focal epilepsy of childhood (Gastaut and Panayiotopolous syndromes: the 2 variants of CEOP)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Photoparoxysmal response",
"      </td>",
"      <td>",
"       Primary generalized epilepsy",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CAE: childhood absence epilepsy; JAE: juvenile absence epilepsy; BECTS: benign focal epilepsy of childhood with centrotemporal spikes; BREC: benign rolandic epilepsy of childhood; CEOP: childhood epilepsy with occipital paroxysms.",
"     <br>",
"      * &gt;90 percent probability of seizures/epilepsy (adults).&yen;",
"      <br>",
"       &bull; 76-91 percent probability of seizures/epilepsy (children).&Dagger;",
"       <br>",
"        &Delta; &sim;75 percent probability of seizures/epilepsy (children).&dagger;",
"        <br>",
"         &loz; &sim;40 percent probability of seizures/epilepsy (children).&dagger;",
"         <br>",
"          &sect; 50 percent probability of seizures/epilepsy (children).&dagger;",
"          <br>",
"           &yen; Pedley, TA, Mendiratta, A, Walczak, TS. Seizures and Epilepsy. In: Current Practice of Clinical Electroencephalography, Ebersole, JS, Pedley, TA (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2003 p.506.",
"           <br>",
"            &Dagger; Ehle, A, Co, S, Jones, MG. Clinical correlates of midline spikes. An analysis of 21 patients. Arch Neurol 1981; 38:355.",
"            <br>",
"             &dagger; Kellaway, P. The incidence, significance and natural history of spike foci in children. In: Current clinical neurophysiology: update on EEG and evoked potentials, Henry, C (Ed), Elsevier, Amsterdam 1981 p.151.",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Table modified and expanded from: Pillai, J, Sperling, MR. Interictal EEG and the diagnosis of epilepsy. Epilepsia 2006; 47 Suppl 1:14.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37500=[""].join("\n");
var outline_f36_39_37500=null;
var title_f36_39_37501="Barthel Index";
var content_f36_39_37501=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F77371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F77371&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Barthel Index",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Activity",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Feeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Unable",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Needs help cutting, spreading butter, etc, or requires modified diet",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Independent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Bathing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Dependent",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Independent (or in shower)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Grooming",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Needs to help with personal care",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Independent face/hair/teeth/shaving (implements provided)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Dressing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Dependent",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Needs help but can do about half unaided",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Independent (including buttons, zips, laces, etc)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Bowels",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Incontinent (or needs to be given enemas)",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Occasional accident",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Continent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Bladder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Incontinent, or catheterized and unable to manage alone",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Occasional accident",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Continent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Toilet use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Dependent",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Needs some help, but can do something alone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Independent (on and off, dressing, wiping)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Transfers (bed to chair and back)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Unable, no sitting balance",
"       </td>",
"       <td rowspan=\"4\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Major help (one or two people, physical), can sit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Minor help (verbal or physical)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        15 = Independent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Mobility (on level surfaces)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Immobile or &lt;50 yards",
"       </td>",
"       <td rowspan=\"4\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Wheelchair independent, including corners, &gt;50 yards",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Walks with help of one person (verbal or physical) &gt;50 yards",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        15 = Independent (but may use any aid; for example, stick) &gt;50 yards",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Stairs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0 = Unable",
"       </td>",
"       <td rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        5 = Needs help (verbal, physical, carrying aid)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        10 = Independent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td align=\"right\">",
"        <strong>",
"         Total (0-100):",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The Barthel ADL Index: Guidelines",
"    <br>",
"     <ul>",
"      <li>",
"       The index should be used as a record of what a patient does, not as a record of what a patient could do",
"      </li>",
"      <li>",
"       The main aim is to establish degree of independence from any help, physical or verbal, however minor and for whatever reason",
"      </li>",
"      <li>",
"       The need for supervision renders the patient not independent",
"      </li>",
"      <li>",
"       Patient performance should be established using the best available evidence provided by the patient, family, friends and caregivers; direct observation and common sense are also important, but direct testing is not needed",
"      </li>",
"      <li>",
"       Usually the patient's performance over the preceding 24 to 48 hours is important, but occasionally longer periods will be relevant",
"      </li>",
"      <li>",
"       Middle categories imply that the patient supplies over 50 percent of the effort",
"      </li>",
"      <li>",
"       Use of aids to be independent is allowed",
"      </li>",
"     </ul>",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      References:",
"      <br>",
"       <ol>",
"        <li>",
"         Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Medical Journal 1965; 14:56. Used with permission.",
"        </li>",
"        <li>",
"         Loewen SC, Anderson BA. Predictors of stroke outcome using objective measurement scales. Stroke 1990; 21:78.",
"        </li>",
"        <li>",
"         Gresham GE, Phillips TF, Labi ML. ADL status in stroke: relative merits of three standard indexes.&rdquo; Arch Phys Med Rehabil 1980; 61:355.",
"        </li>",
"        <li>",
"         Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. Int Disability Study 1988; 10:61.",
"        </li>",
"       </ol>",
"      </br>",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37501=[""].join("\n");
var outline_f36_39_37501=null;
var title_f36_39_37502="Exercise in T1DM";
var content_f36_39_37502=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F60391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F60391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Metabolic effects of exercise in type 1 diabetes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 253px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Comparison of the effects of exercise in normal subjects and patients with type 1 diabetes who are in control or poorly controlled (ketotic). Exercise modestly lowered blood glucose concentrations and raised blood ketone concentrations in the normal subjects and in well-controlled diabetic patients. In the latter group, the fall in blood glucose is somewhat more prominent since exogenous insulin prevents plasma insulin concentrations from falling, thereby maintaining both muscle glucose utilization and inhibition of hepatic glucose output. In comparison, the lack of availability of insulin in poorly controlled diabetic patients prevents the fall in blood glucose and augments the increase in ketogenesis. To convert blood glucose values to mmol/L, multiply by 0.056.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Berger M, Berchtold P, Cuppers HJ, et al. Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia 1977; 13:355.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37502=[""].join("\n");
var outline_f36_39_37502=null;
var title_f36_39_37503="High grade cystic duct leak I";
var content_f36_39_37503=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    High grade cystic stump leak after cholecystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 388px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    ERCP demonstrating extravasation of contrast with minimal filling of the intraheptic bile ducts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael J Bourke, MBBS, FRACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_39_37503=[""].join("\n");
var outline_f36_39_37503=null;
